VBI Vaccines Announces Poster Presentation at 2024 ASCO Annual Meeting Highlighting New Interim Phase 2b Data from VBI-1901 in Recurrent Glioblastoma Patients May 22, 2024 08:00 AM Eastern ...

Zentalis Pharmaceuticals, Inc. announced that an abstract has been accepted for a poster presentation at the 2025 American Society of Clinical Oncology Annual Meeting, scheduled for May 30 to June ...

TScan Therapeutics announced an accepted abstract for poster presentation at ASGCT's annual meeting on TCR-engineered therapies for cancer. TScan Therapeutics, Inc., a clinical-stage biotechnology ...

Details for the poster presentation are as follows: Abstract: P002 Session: Clinical Studies in AML and ALL Title:Liposomal Annamycin in Combination with Cytarabine for Treatment of Acute Myeloid ...

Judging Criteria (In-person Poster Presentations) Judges will be scoring your poster presentation and will look for the following criteria: Medical student’s appearance: Well-prepared, engaged, ...

A Collaborative Practice I student team presented a poster presentation at the NEXUS Summit, titled “Engagement Plan for Increasing Representation in Biomedical Research: A Community Collaboration ...

Below are the judging criteria and points available to be earned for the poster sessions. Remember to add your abstract to your poster! Also, bonus points can be awarded for a good, professional ...

We are accepting abstracts for poster or oral presentations online. The abstracts should include: the title and authors; and should be less than 250 words in length (excluding title and authors). The ...